6505--Montelukast 10mg Tablet

The Department of Veterans Affairs National Acquisition Center will be releasing a Request for Proposal for an unrestricted procurement contract for Montelukast 10mg tablets, primarily for use by various federal agencies including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract is structured for a base year with four pre-priced one-year options, and the awarded supplier must guarantee a continuous supply of the specified medication. Distribution will occur through the VA and DoD Pharmaceutical Prime Vendor Programs. Contract requirements include the supply of Montelukast tablets in various bottle sizes—30, 90, 500, and 1000-count units—with specific packaging criteria such as unique NDC numbers per offeror, safety-cap features, cylindrical bottles, and label dimensions to accommodate barcodes and expiration/lot numbers. The estimated annual quantities for the contract are significant, with approximately 62,485 bottles of 30-count, 699,070 bottles of 90-count, and either 77,256 bottles of 500-count or 38,628 bottles of 1000-count tablets anticipated. Offerors must provide the exact name and unique NDC as it appears on the supplied label, ensuring no relabeling over an existing product. The official solicitation (No. 36E79725R0061) is expected to be posted around September 30, 2025, with proposals due by October 10, 2025. All communications and questions regarding the procurement are to be directed to Kenneth Lay, the contract specialist, as paper copies of the solicitation will not be provided and updates will be available exclusively on SAM.gov.